The Nasdaq-listed biotechnology firm is raising $425 million for its ETH strategy, joining a parade of penny stocks investing in cryptocurrencies as their business flounders.
You might also be interested in reading XRP Aims For $0.50, Hinges on Breaking Through This Price Level.